Human choriogonadotropin and epoetin alfa in acute ischemic stroke patients (REGENESIS-LED trial)

International Journal of Stroke

Volumn 9, Issue 3, 2014, Pages 321-327

  Cramer, Steven C ^a   Hill, Michael D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Clinical trial; Growth factor; Restorative; Safety; Stroke recovery

Indexed keywords

CHORIONIC GONADOTROPIN ALPHA SUBUNIT; PLACEBO; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ASIAN; BODY HEIGHT; BODY WEIGHT; BRAIN ISCHEMIA; CAUCASIAN; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY DISEASE; DEATH; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DISEASE CLASSIFICATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FEMALE; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERTENSION; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RACE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS; STROKE PATIENT; SUDDEN CARDIAC DEATH; TOBACCO USE;

CLINICAL TRIAL; GROWTH FACTOR; RESTORATIVE; SAFETY; STROKE RECOVERY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CHORIONIC GONADOTROPIN; COHORT STUDIES; DOUBLE-BLIND METHOD; ERYTHROPOIETIN; FEMALE; HEMATINICS; HUMANS; INTERNATIONAL COOPERATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; OUTCOME ASSESSMENT (HEALTH CARE); RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTORS; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84896317374     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12260     Document Type: Article

References (14)

1. Chollet F, Tardy J, Albucher JF etal. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 2011; 10:123-130.
2. Scheidtmann K, Fries W, Muller F, Koenig E. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet 2001; 358:787-790.
3. Cramer SC. Repairing the human brain after stroke. II. Restorative therapies. Ann Neurol 2008; 63:549-560.
4. Ren JM, Finklestein SP. Growth factor treatment of stroke. Curr Drug Targets CNS Neurol Disord 2005; 4:121-125.
5. Floel A, Cohen LG. Recovery of function in humans: cortical stimulation and pharmacological treatments after stroke. Neurobiol Dis 2010; 37:243-251.
6. Weiss S, Reynolds BA, Vescovi AL, Morshead C, Craig CG, van der Kooy D. Is there a neural stem cell in the mammalian forebrain? Trends Neurosci 1996; 19:387-393.
7. Kolb B, Morshead C, Gonzalez C etal. Growth factor-stimulated generation of new cortical tissue and functional recovery after stroke damage to the motor cortex of rats. J Cereb Blood Flow Metab 2007; 27:983-997.
8. Belayev L, Khoutorova L, Zhao KL, Davidoff AW, Moore AF, Cramer SC. A novel neurotrophic therapeutic strategy for experimental stroke. Brain Res 2009; 1280:117-123.
9. Cramer SC, Fitzpatrick C, Warren M etal. The beta-hCG+erythropoietin in acute stroke (BETAS) study: a 3-center, single-dose, open-label, noncontrolled, phase IIa safety trial. Stroke 2010; 41:927-931.
10. Ehrenreich H, Weissenborn K, Prange H etal. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 2009; 40:e647-656.
11. Feeney D, Gonzalez A, Law W. Amphetamine, halperidol, and experience interact to affect the rate of recovery after motor cortex injury. Science 1982; 217:855-857.
12. Kleim JA, Jones TA. Principles of experience-dependent neural plasticity: implications for rehabilitation after brain damage. J Speech Lang Hear Res 2008; 51:S225-239.
13. Caplan LR, Arenillas J, Cramer SC etal. Stroke-Related Translational Research. Arch Neurol 2011; 68:1110-1123.
14. Cramer S, Chopp M. Recovery recapitulates ontogeny. Trends Neurosci 2000; 23:265-271.